Controversies of renin–angiotensin–aldosterone system inhibitors usage in patients with COVID-19 and meticulous handling of case with acute coronary syndrome categorically stresses cardiologists to bust the myths hovering around and set a standard guideline to counterfeit the fatality with timely diagnosis and treatment of COVID-19–induced ACI. The gene discussed is REN; the disease is acute coronary syndrome.